Alyeska Investment Group L.P. Has $120.37 Million Stock Holdings in Masimo Corporation $MASI

Key Points

• Alyeska Investment Group L.P. increased its position in Masimo Corporation by 24.9% in the first quarter, owning about 722,534 shares valued at approximately $120.37 million.
• Masimo's latest earnings report showed an EPS of $1.33, surpassing expectations, with quarterly revenue rising by 7.7% year-over-year.
• Analysts have mixed ratings on Masimo stock, with a consensus of “Moderate Buy” and an average target price of $193.60.

Alyeska Investment Group L.P. increased its position in shares of Masimo Corporation (NASDAQ:MASI - Free Report) by 24.9% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 722,534 shares of the medical equipment provider's stock after purchasing an additional 143,899 shares during the period. Alyeska Investment Group L.P. owned approximately 1.33% of Masimo worth $120,374,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also added to or reduced their stakes in the company. Xponance Inc. lifted its holdings in Masimo by 1.1% during the 1st quarter. Xponance Inc. now owns 7,101 shares of the medical equipment provider's stock worth $1,183,000 after purchasing an additional 76 shares during the last quarter. Deutsche Bank AG raised its holdings in Masimo by 1.5% in the 1st quarter. Deutsche Bank AG now owns 6,309 shares of the medical equipment provider's stock valued at $1,051,000 after acquiring an additional 92 shares in the last quarter. State of Michigan Retirement System raised its holdings in Masimo by 1.0% in the 1st quarter. State of Michigan Retirement System now owns 10,596 shares of the medical equipment provider's stock valued at $1,765,000 after acquiring an additional 100 shares in the last quarter. Louisiana State Employees Retirement System raised its holdings in Masimo by 0.8% in the 1st quarter. Louisiana State Employees Retirement System now owns 12,400 shares of the medical equipment provider's stock valued at $2,066,000 after acquiring an additional 100 shares in the last quarter. Finally, Securian Asset Management Inc. raised its holdings in Masimo by 3.0% in the 1st quarter. Securian Asset Management Inc. now owns 3,433 shares of the medical equipment provider's stock valued at $572,000 after acquiring an additional 100 shares in the last quarter. 85.96% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on MASI shares. Wall Street Zen lowered Masimo from a "buy" rating to a "hold" rating in a research report on Friday, May 30th. Zacks Research upgraded Masimo from a "hold" rating to a "strong-buy" rating in a research report on Wednesday. Piper Sandler boosted their price objective on Masimo from $200.00 to $210.00 and gave the stock an "overweight" rating in a research report on Wednesday, August 6th. Finally, BTIG Research restated a "buy" rating on shares of Masimo in a research report on Thursday, August 14th. One investment analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and one has assigned a Hold rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Buy" and an average price target of $193.60.

Masimo Trading Up 2.9%

Shares of NASDAQ MASI traded up $4.18 during trading on Friday, reaching $147.19. The company had a trading volume of 693,981 shares, compared to its average volume of 649,554. The company's fifty day moving average price is $154.41 and its 200-day moving average price is $160.39. Masimo Corporation has a 12 month low of $107.98 and a 12 month high of $194.88. The stock has a market cap of $8.00 billion, a P/E ratio of -17.28 and a beta of 1.23. The company has a quick ratio of 1.61, a current ratio of 2.14 and a debt-to-equity ratio of 0.57.

Masimo (NASDAQ:MASI - Get Free Report) last released its quarterly earnings results on Tuesday, August 5th. The medical equipment provider reported $1.33 EPS for the quarter, beating analysts' consensus estimates of $1.22 by $0.11. Masimo had a positive return on equity of 26.54% and a negative net margin of 24.85%.The firm had revenue of $370.90 million for the quarter, compared to analyst estimates of $368.65 million. During the same quarter in the previous year, the company posted $0.86 EPS. The business's revenue was up 7.7% on a year-over-year basis. As a group, research analysts expect that Masimo Corporation will post 4.1 earnings per share for the current year.

Insider Activity at Masimo

In related news, Director William R. Jellison purchased 3,000 shares of Masimo stock in a transaction on Monday, August 11th. The shares were purchased at an average price of $145.98 per share, for a total transaction of $437,940.00. Following the transaction, the director owned 4,790 shares of the company's stock, valued at approximately $699,244.20. This represents a 167.60% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this hyperlink. Company insiders own 9.70% of the company's stock.

About Masimo

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.